IMF Videos Search Content For Care Partner (57) Patient (55) Healthcare Provider (19) Healthcare Professional (18) Series - Any - ASCO/EHA (2) ASH (14) Ask Dr. Durie (40) Black Swan Research Initiative (1) Facebook Live (3) Living Well with Myeloma (1) Myeloma in a Minute (1) Patient & Family Webinar (1) Q&A (7) Topics Clinical Trials (186) Financial Considerations (15) Frontline Therapy (84) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (72) Lifestyle (47) Mental & Emotional Health (29) Myeloma 101 (59) Myeloma in the News (8) Public Policy & Advocacy (17) Q&A's (43) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (138) Research Updates (194) Symptom Management (115) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (14) High-Risk Myeloma (12) High-risk Smoldering Myeloma (14) Late Relapse (4–6 Lines of Therapy) (12) MGUS (26) Newly Diagnosed (Pre-Treatment or First Treatment) (23) Smoldering Myeloma (31) Types of Therapy Immunomodulatory drugs (IMiDs) (10) Immunotherapies (CAR T; BiTE, etc.) (11) Monoclonal antibodies (9) Proteasome inhibitors (7) Stem cell transplant (9) Steroids (4) Supportive Care (21) Year Published 2026 (6) 2025 (4) 2024 (9) 2023 (8) 2022 (10) 2021 (5) 2020 (4) 2019 (9) 2018 (1) 2017 (8) 2016 (4) 2015 (4) Trusted Voices Dr. Brian GM Durie (36) Dr. Joseph Mikhael (8) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Dr. Sigurður Kristinsson (2) Dr. María-Victoria Mateos (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Q&A: Myeloma Insights with Nurse Leadership Experts | Early Detection, Treatment & Support September 25, 2024 Facebook Live What does the FDA approval of MRD testing for myeloma mean for patients and drug development? June 20, 2024 Ask Dr. Durie Do patients with MGUS always need to undergo a bone marrow test? April 25, 2024 Ask Dr. Durie What are CRAB and pre-CRAB criteria in myeloma diagnosis, and how do they affect treatment decision-making? April 16, 2024 Ask Dr. Durie Ask Me Anything Replay: Insights from IMF NLB Member Beth Faiman March 27, 2024 Facebook Live What is the significance of mass spectrometry in measuring myeloma protein levels? March 7, 2024 Ask Dr. Durie Iceland’s iStopMM Study Revises Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance (MGUS) January 8, 2024 ASH Ask Me Anything Replay: Exploring Myeloma Research Breakthroughs with Dr. Joseph Mikhael October 23, 2023 Facebook Live What is minimal residual disease (MRD)? May 4, 2023 Ask Dr. Durie Monoclonal Gammopathy of Undetermined Significance (MGUS) with Multiple Paraproteins: Results from iStopMM February 1, 2023 ASH Is there a new highly sensitive blood test to detect minimal residual disease? January 26, 2023 Ask Dr. Durie Are mass spectrometry and next-generation flow useful tests to evaluate minimal residual disease (MRD)? January 19, 2023 Ask Dr. Durie Load More